Clinical study of pazufloxacin mesilate, a new quinolone antibacterial agent, in burn infections and tissue concentrations

Japanese Journal of Chemotherapy

Volumn 48, Issue 6, 2000, Pages 401-416

  Sugihara, T ^a   Yoshida, T ^a   Minagawa, H ^a   Kawashima, K ^a   Horiuchi, K ^a   Honda, K ^a   Takeuchi, A ^a   Homma, K ^a   Maeda, K ^a   Takeno, N ^a   Kimura, C ^a   Tsutsumida, A ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Pazufloxacin

Indexed keywords

ANTIINFECTIVE AGENT; BACITRACIN; BETA LACTAM DERIVATIVE; CEFAZOLIN; CEFOTIAM; CEPHEM DERIVATIVE; CHLORPHENIRAMINE MALEATE; DIPYRIDAMOLE; FAMOTIDINE; FLOMOXEF; INSULIN; LOXOPROFEN; MANIDIPINE; NEOMYCIN; OXYTETRACYCLINE; PAZUFLOXACIN; POLYMYXIN B; PRAVASTATIN; PROBUCOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFADIAZINE SILVER;

ADULT; AGED; ARTICLE; BURN INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TISSUE LEVEL; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PHASE 3 CLINICAL TRIAL;

EID: 0033938597     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)